[HTML][HTML] Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O)
Background Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
[PDF][PDF] Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O)
UO Edet, FO Nwaokorie, EN Mbim, EE Asanga… - 2022 - academia.edu
Background: Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O).
UO Edet, FO Nwaokorie, EN Mbim… - BMC …, 2022 - search.ebscohost.com
Background: Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O).
UO Edet, FO Nwaokorie, EN Mbim… - BMC Complementary …, 2022 - europepmc.org
Background Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
[PDF][PDF] Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O)
UO Edet, FO Nwaokorie, EN Mbim, EE Asanga… - 2022 - d-nb.info
Background: Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
[HTML][HTML] Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O)
UO Edet, FO Nwaokorie… - BMC …, 2022 - bmccomplementmedtherapies …
Staphylococcus aureus has prevailed against the majority of antibiotics currently in clinical
use, making it a significant global public health problem. As a safer alternative, bioactive …
use, making it a significant global public health problem. As a safer alternative, bioactive …
Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O)
UO Edet, FO Nwaokorie, EN Mbim… - BMC …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against capsular protein (Cap5o).
UO Edet, FO Nwaokorie, EN Mbim, EE Asanga… - 2022 - cabidigitallibrary.org
Background: Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
[PDF][PDF] Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O)
UO Edet, FO Nwaokorie, EN Mbim, EE Asanga… - 2022 - researchgate.net
Background: Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …
[HTML][HTML] Evaluation of Annona muricata extract against Staphylococcus aureus isolate and in-silico activity of bioactive compounds against Capsular protein (Cap5O)
UO Edet, FO Nwaokorie, EN Mbim… - BMC Complementary …, 2022 - ncbi.nlm.nih.gov
Background Staphylococcus aureus has prevailed against the majority of antibiotics
currently in clinical use, making it a significant global public health problem. As a safer …
currently in clinical use, making it a significant global public health problem. As a safer …